Skip to main content

Femtrace Warner Chilcott - Treatment for Menopausal Vasomotor Symptoms

Femtrace has been approved for the relief of the vasomotor symptoms of menopause. Approval was not granted for the secondary indication of vulvar-vaginal atrophy. The comapny expects to launch Femtrace in the first quarter of 2005.

Femtrace (estradiol acetate) FDA Approval History

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.